Waystar Moves From AI Insights to Agentic Execution Across the Revenue Cycle

The autonomous-RCM race is moving from copilots and recommendations toward software that actually takes action. Waystar's newest AltitudeAI release makes that transition explicit.

One day after reorganizing its executive leadership around an autonomous revenue-cycle vision, Waystar unveiled a new set of AltitudeAI capabilities designed to execute work across revenue-cycle workflows. The timing matters. The leadership announcement described the operating model; this product release shows what Waystar intends that model to deliver.

The most consequential capability is autonomous claim resolution. Waystar says specialized agents can interpret payer responses, apply payer-specific intelligence, determine the next action and automatically resubmit eligible rejected and denied claims with minimal human intervention.

Claims are the proving ground

Denied and rejected claims are a natural place to test agentic RCM because the workflow is repetitive, measurable and economically meaningful. Waystar says payers ultimately pay roughly 70% of initially denied claims, but providers often incur additional labor and delay to get those claims resolved.

An agent that can reliably interpret a payer response, select an appropriate action and resubmit a claim begins to attack that rework directly. It also changes the role of the RCM employee: fewer routine touches, more exception management, oversight and escalation.

Waystar is building across the workflow

The release extends beyond claims. Waystar is embedding conversational intelligence into analytics, where early adopters have reported up to a 75% reduction in analysis time. It is expanding agentic clinical-documentation workflows that can analyze approximately 30,000 medical-record data points and organize evidence for specialist review. And it is developing an agentic patient-financial concierge that uses context across the financial journey to guide patients through balances and payment decisions.

Those capabilities sit on top of a significant data and connectivity advantage. Waystar says its platform spans more than 7.5 billion transactions and touches approximately 60% of U.S. patients. In an agentic model, that breadth matters because execution quality depends not only on the model but on payer-specific context, workflow integration and feedback from prior outcomes.

The competitive question is changing

For the last several years, much of the RCM AI market has competed on prediction, prioritization and workflow assistance. The next phase will increasingly be judged on execution: which platforms can safely take actions, close loops and demonstrate measurable financial outcomes without requiring a human click at every step.

That raises the bar for both incumbents and AI-native challengers. Point solutions may still outperform on narrow workflows, but scaled platforms have an opportunity to connect agents across claims, denials, CDI, analytics and patient payments. The strategic advantage shifts toward orchestration.

What RevCycleAI is watching

The key metric is no longer the number of AI features announced. It is the percentage of revenue-cycle work that can move from identification through resolution autonomously, with appropriate controls and auditable outcomes.

Waystar's autonomous claim-resubmission capability is therefore more important than another generative-AI interface. If it performs reliably at scale, it represents a concrete step toward the autonomous revenue cycle the industry has been describing for years.

RevCycleAI take: the autonomous-RCM narrative is becoming an execution race. Waystar has the transaction volume, payer connectivity and workflow footprint to be a serious contender. The next question is how much work these agents can actually resolve end-to-end—and what measurable labor, denial and cash-acceleration outcomes customers report.

Source: Waystar announcement →